Healthtech has one of the biggest events in all of B2B — HIMSS26 pulled more than 24,000 healthcare and technology leaders to Las Vegas in March 2026, with 900+ exhibitors and roughly 75% of attendees classified as decision-makers or influencers. That density is real. What's also real: almost none of those conversations turn into a signed contract inside the same quarter, because health system buying doesn't work like the rest of B2B.
Why a great HIMSS meeting still means a long wait
Nearly a third of HIMSS26 attendees came from the C-suite, and the event runs a structured Hosted Buyer Program specifically to move health system purchasing leaders past small talk into substantive procurement discussions. That's a good sign for pipeline generation — but it doesn't shorten the buying cycle behind it. Healthcare IT deals still run 9 to 18 months on average for enterprise health systems, and a 2024 Bain & Company study found 71% of provider technology purchases involve five or more stakeholders — with deals 2.4x more likely to stall when a vendor engages only one persona.
The single longest gate in that timeline usually isn't procurement paperwork; it's security and compliance review, which typically takes 60 to 120 days on its own and can run longer than the rest of the sales cycle combined. If your team treats a HIMSS conversation as the start of a normal SaaS cycle, you'll be surprised months later by a Value Analysis Committee, a HIPAA security questionnaire, or a BAA negotiation you didn't budget time for.
Map the buying committee before you book a meeting
Because a health system deal rarely closes on the strength of one champion, the pre-event work is less about finding a single contact and more about mapping a full committee: the CIO or IT director (technical authority), the CMIO or a clinical champion (workflow fit), the compliance or privacy officer (HIPAA and data governance), and the CFO or VP of finance (budget). Missing any one of these people at a conference means starting a fresh outreach thread months later, at exactly the point competitors who met the whole committee are already in security review.
Use the attendee list to work backward from your target accounts, not forward from the badge scans. /platform scores exhibitor and attendee lists against your ICP so you can see, before the show opens, which named accounts have multiple buying-committee roles registered — not just whether an account is "attending."
Front-load compliance, don't wait for it to ambush you
The teams that compress healthcare IT cycles start compliance conversations in parallel with clinical evaluation, not after a verbal commitment. That means treating an event conversation with a compliance officer or CISO as seriously as one with a clinical sponsor, and having a security packet — SOC 2 report, HIPAA safeguards summary, BAA template — ready to hand off on the spot rather than promising to "send something over." Health systems increasingly run 200-400 question security reviews for enterprise deals, and the vendors who show up prepared to start that review immediately after the show are the ones who shave months off the cycle rather than adding them.
The /sales playbook has healthcare-specific outreach templates that speak to each committee role differently — compliance-first messaging for the privacy officer, workflow-first messaging for the clinical champion — instead of one generic "great meeting you at HIMSS" follow-up sent to everyone.
Measure the event on committee coverage, not meeting count
A HIMSS or regional health IT show shouldn't be scored on total meetings booked. Score it on how many named accounts you covered across at least three buying-committee roles, and how many of those accounts moved into a formal security or clinical evaluation within 90 days. Ten accounts with the CIO, compliance officer, and a clinical sponsor all engaged will outperform fifty accounts where you only ever talked to one person — because in a market where 71% of deals need five-plus stakeholders to sign off, single-threaded pipeline is the thing most likely to die quietly in committee review next quarter.
Healthtech events are worth the travel budget precisely because the buyer density is unusually high. The return on that density depends entirely on whether your team plans for an 18-month, multi-stakeholder sale from day one — or discovers it the hard way in month nine.